首页> 外文期刊>Autoimmunity >Circulating level of the platelet-derived CXC chemokine platelet factor 4 in chronic urticaria patients with or without coexistent euthyroid Hashimoto's thyroiditis.
【24h】

Circulating level of the platelet-derived CXC chemokine platelet factor 4 in chronic urticaria patients with or without coexistent euthyroid Hashimoto's thyroiditis.

机译:患有或不伴有正常甲状腺功能正常桥本甲状腺炎的慢性荨麻疹患者中血小板衍生的CXC趋化因子血小板因子4的循环水平。

获取原文
获取原文并翻译 | 示例
           

摘要

The concept of autoimmune aetiology of some cases of chronic urticaria (CU) has been supported by several observation including wheal-and-flare reaction induced by intradermal injection of autologous serum as well as association with other autoimmune diseases, in particular Hashimoto's thyroiditis (HT). It is known that activated platelets may actively participate in immune-inflammatory processes. Therefore, we assessed whether autoimmune phenomenon associated with CU influence the systemic platelet activity measured by circulating level of platelet factor 4 (PF-4). Plasma level of PF-4 was analysed using enzyme-linked immunosorbent assay in twelve women with strong positive response to autologous serum skin test (ASST) suffering from CU, twelve female patients with strong positive ASST suffering from both CU and untreated, HT as well as sixteen healthy women. All the subjects were clinically and biochemically euthyroid. There were no statistically significant differences between the CU patients with or without euthyroid HT and plasma PF-4 level in healthy controls. In patients with both CU and thyroiditis, plasma level of PF-4 did not correlate significantly with the level of antibodies against thyroperoxidase. It seems that circulating level of the platelet-derived chemokine is not increased in CU patients with positive response to ASST, regardless the occurrence of euthyroid HT.
机译:一些慢性荨麻疹(CU)病例的自身免疫病因学概念得到了以下观察的支持,包括皮内注射自体血清引起的风疹和耀斑反应以及与其他自身免疫性疾病,特别是桥本甲状腺炎(HT) 。已知活化的血小板可以积极参与免疫炎症过程。因此,我们评估了与CU相关的自身免疫现象是否会影响通过血小板因子4(PF-4)循环水平测得的全身性血小板活性。使用酶联免疫吸附测定法分析了12例对CU的自体血清皮肤试验(ASST)有强阳性反应的女性,12例CU和未经治疗的HT的强阳性ASST的女性患者的血浆PF-4水平作为十六位健康的女性。所有受试者在临床和生化方面均正常。在健康对照组中,有或没有甲亢性HT和血浆PF-4水平的CU患者之间没有统计学上的显着差异。在患有CU和甲状腺炎的患者中,PF-4的血浆水平与针对甲状腺过氧化物酶的抗体水平没有显着相关。似乎,对ASST有阳性反应的CU患者,血小板源性趋化因子的循环水平不会增加,而与正常甲状腺HT无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号